- ByInvesting.com-
Investing.com -- JSW SA (WSE:JSW) announced that discussions between its management board and trade unions regarding temporary...
Last | High | Low | |||||
|---|---|---|---|---|---|---|---|
| 556.20 | 564.40 | 552.80 | -4.00 | -0.71% | 208.98K | ||
| 87.46 | 88.56 | 87.00 | -0.50 | -0.57% | 4.95M | ||
| 1,066.00 | 1,109.50 | 1,062.00 | -33.00 | -3.00% | 25.79K | ||
| 10.09 | 10.31 | 10.04 | -0.13 | -1.27% | 697.71K | ||
| 211.20 | 213.40 | 209.30 | 0.00 | 0.00% | 705.38K | ||
| 296.50 | 297.30 | 286.50 | +13.00 | +4.59% | 1.29M | ||
| 99.75 | 101.58 | 99.60 | -1.55 | -1.53% | 2.4M | ||
| 9.02 | 9.23 | 8.93 | -0.08 | -0.88% | 3.04M | ||
| 68.14 | 69.20 | 67.70 | -0.36 | -0.53% | 1.82M | ||
| 114.50 | 116.20 | 113.65 | +0.40 | +0.35% | 184.19K | ||
| 636.60 | 645.00 | 633.40 | -5.00 | -0.78% | 25.39K | ||
| 121.00 | 122.20 | 118.75 | -0.20 | -0.17% | 307.27K | ||
| 239.40 | 245.50 | 238.10 | -2.30 | -0.95% | 245.09K | ||
| 498.50 | 502.20 | 495.10 | +0.10 | +0.02% | 39.62K | ||
| 921.00 | 941.00 | 917.00 | -10.00 | -1.07% | 13.26K | ||
| 21,340 | 21,410 | 21,040 | +140 | +0.66% | 3.49K | ||
| 41.09 | 41.41 | 40.78 | +0.09 | +0.22% | 3.18M | ||
| 31.36 | 31.47 | 30.92 | +0.11 | +0.35% | 4.55M | ||
| 31.09 | 31.24 | 30.63 | +0.11 | +0.36% | 967.37K | ||
| 23.00 | 23.35 | 22.86 | -0.20 | -0.86% | 3.39M |
Investing.com -- JSW SA (WSE:JSW) announced that discussions between its management board and trade unions regarding temporary...
Investing.com -- Grupa Azoty SA announced that its unit Grupa Azoty Polyolefins has filed an arbitration claim against Hyundai...
Investing.com -- KGHM Polska Miedz SA (WA:KGH) shares fell on Thursday after the Polish mining company issued 2026 guidance...
Demand for home-improvement products is closely aligned with housing-market fundamentals. Because many homeowners renovate prior...
SAIL Share Fundamental Analysis : Although there are lakhs of shares listed in the stock market, today we are going to tell you...
Eli Lilly’s (NYSE:LLY) upcoming earnings report will be closely watched as it solidifies its lead in the weight-loss drug market....
No Earning Reports have been scheduled